Amended Report of Foreign Issuer (6-k/a)
August 10 2017 - 4:19PM
Edgar (US Regulatory)
UNITED STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
Amendment
No. 1 to
Form 6-K/A
REPORT OF
FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 OF THE SECURITIES EXCHANGE ACT OF 1934
For
the month of
August, 2017
|
|
Commission
File Number
000-29338
|
CARDIOME
PHARMA CORP.
|
(Translation
of registrant's name into English)
|
1441
Creekside Drive, 6th Floor
Vancouver,
British Columbia, Canada V6J 4S7
|
(Address
of principal executive offices)
|
Indicate
by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:
Form 20-F
¨
Form 40-F
x
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):
Indicate
by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):
EXPLANATORY
NOTE
The report on Form 6-K dated March
7, 2017 incorrectly stated the file number of the registration statement on Form F-10 into which Exhibit 99.1 (Material Change
Report Dated March 7, 2017) should be incorporated by reference.
This report on Form 6-K/A is furnished
solely to incorporate by reference such Exhibit 99.1 into Cardiome Pharma Corp.’s registration statement on Form F-10
(File No. 333-209606) in addition to the registration statements on Form S-8 (File No. 333-199091 and File No. 333-199092).
SIGNATURES
Pursuant to
the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf
by the undersigned, thereunto duly authorized.
|
CARDIOME
PHARMA CORP.
|
|
(Registrant)
|
Date:
|
|
August 10, 2017
|
|
By:
|
/s/
Justin Renz
|
|
Name: Justin Renz
Title: Chief Financial
Officer
|
|
|
|
|
|
|
Correvio Pharma (NASDAQ:CORV)
Historical Stock Chart
From Apr 2024 to May 2024
Correvio Pharma (NASDAQ:CORV)
Historical Stock Chart
From May 2023 to May 2024